Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.

N. K. Cheung, L. Burch, B. H. Kushner, David H Munn

Research output: Contribution to journalArticlepeer-review

27 Scopus citations
Original languageEnglish (US)
Pages (from-to)395-400
Number of pages6
JournalProgress in Clinical and Biological Research
StatePublished - Jan 1 1991
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this